Cycurion, Inc. (CYCU) 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring between October 14, 2025, and October 20, 2025. Cycurion, Inc., a Delaware corporation, is an emerging growth company with common stock (CYCU) and redeemable warrants (CYCUW) listed on The Nasdaq Global Market. The filing primarily addresses a delisting determination from Nasdaq and recent corporate actions.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue totals, profit margins, cash flow, or debt levels for a specific reporting period. However, it notes the following specific financial data points:
- New Contracts: On October 16, 2025, the company closed five new contracts totaling approximately $1 million in value.
- Recurring Revenue Impact: These contracts are expected to generate an additional $75,000 in monthly recurring revenue.
- Stock Price: The company failed to maintain a closing bid price of at least $1.00 per share for 30 consecutive business days prior to April 9, 2025.
Material Changes and Corporate Actions
The most significant material change is the initiation of delisting proceedings by Nasdaq due to non-compliance with the Minimum Bid Price Rule (Rule 5550(a)(2)).
- Delisting Notice: On October 14, 2025, Nasdaq staff determined to commence proceedings to delist the company's common stock after the company failed to regain compliance by the October 6, 2025 deadline.
- Reverse Stock Split: On October 10, 2025, the Board approved a 30:1 reverse stock split, effective September 29, 2025, with an expected implementation date of October 27, 2025, to regain compliance.
- Appeal Filed: On October 20, 2025, the company submitted a request to appeal the delisting determination to a Nasdaq Hearings Panel. This appeal stays the suspension of trading pending the Panel's decision.
- Legal Action: On October 14, 2025, the company engaged counsel to pursue legal remedies against parties disseminating false and misleading information intended to harm the company's reputation.
Outlook, Risks, and Contingencies
Management's outlook is contingent on the outcome of the Nasdaq appeal and the effectiveness of the reverse stock split.
- Delisting Risk: If the appeal is unsuccessful or compliance is not regained, shares may be delisted from Nasdaq and move to the over-the-counter (OTC) market. The company warns that the OTC market is less liquid and could depress share prices.
- Appeal Timeline: Hearings are typically scheduled 30-45 days after the request date.
- Forward-Looking Risks: Risks include the ability to service debt obligations (including convertible notes), market acceptance of new services, and the ability to secure sufficient capital to operate.
Investor Verification Checklist
- Verify the status of the Nasdaq Hearings Panel appeal and the scheduled hearing date.
- Confirm the effective date and execution of the 30:1 reverse stock split on October 27, 2025.
- Monitor whether the post-split stock price meets the $1.00 minimum bid price requirement.
- Review the company's liquidity position and ability to service convertible note debt, as highlighted in the risk factors.
- Assess the potential impact of a move to the OTC market on share liquidity and trading volume.